Literature DB >> 25576496

National Institutes of Health funding for behavioral interventions to prevent chronic diseases.

Chris Calitz1, Keshia M Pollack2, Chris Millard3, Derek Yach4.   

Abstract

Chronic non-communicable diseases (NCDs) cause the majority of premature deaths, disability, and healthcare expenditures in the U.S. Six largely modifiable risk behaviors and factors (tobacco use, poor nutrition, physical inactivity, alcohol abuse, drug abuse, and poor mental health) account for more than 50% of premature mortality and considerably more morbidity and disability. The IOM proposed that population burden of disease and preventability should be major determinants of the amount of research funding provided by the U.S. NIH. Data on NIH prevention funding between fiscal years 2010 and 2012 for human behavioral interventions that target the modifiable risk factors of NCDs were analyzed during 2013-2014. The NIH prevention portfolio comprises approximately 37% human behavioral studies and 63% basic biomedical, genetic, and animal studies. Approximately 65% of studies were secondary prevention versus 23% for primary prevention, and 71% of studies intervened at the individual and family levels. Diet and exercise were the most-studied risk factors (41%), and few studies conducted economic analyses (12%). NIH spends an estimated $2.2-$2.6 billion annually (7%-9% of the total of $30 billion) on human behavioral interventions to prevent NCDs. Although NIH prevention funding broadly aligns with the current burden of disease, overall funding remains low compared to funding for treatment, which suggests funding misalignment with the preventability of chronic diseases.
Copyright © 2015 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25576496     DOI: 10.1016/j.amepre.2014.10.015

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  8 in total

Review 1.  Obesity Genes, Personalized Medicine, and Public Health Policy.

Authors:  Timothy Caulfield
Journal:  Curr Obes Rep       Date:  2015-09

2.  Preparing Students to Engage in Public Health Research of Consequence.

Authors:  Barbara K Rimer
Journal:  Am J Public Health       Date:  2016-09       Impact factor: 9.308

3.  NIH Primary and Secondary Prevention Research in Humans During 2012-2017.

Authors:  David M Murray; Jennifer Villani; Ashley J Vargas; Jocelyn A Lee; Ranell L Myles; Jessica Y Wu; Patricia L Mabry; Sheri D Schully
Journal:  Am J Prev Med       Date:  2018-10-25       Impact factor: 5.043

Review 4.  The commercialization of university-based research: Balancing risks and benefits.

Authors:  Timothy Caulfield; Ubaka Ogbogu
Journal:  BMC Med Ethics       Date:  2015-10-14       Impact factor: 2.652

5.  Mapping public health research across the National Institute for Health Research 2006-2013.

Authors:  Eleanor Woodford Guegan; Hannah Dorling; Liz Ollerhead; Matt Westmore
Journal:  BMC Public Health       Date:  2016-08-31       Impact factor: 3.295

6.  The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.

Authors:  Haijiang Dai; Tariq A Alsalhe; Nasr Chalghaf; Matteo Riccò; Nicola Luigi Bragazzi; Jianhong Wu
Journal:  PLoS Med       Date:  2020-07-28       Impact factor: 11.069

7.  The global burden and temporal trend of cancer attributable to high body mass index: Estimates from the Global Burden of Disease Study 2019.

Authors:  Xing Zhi; Xiao-Hong Kuang; Kuan Liu; Jian Li
Journal:  Front Nutr       Date:  2022-07-26

8.  Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities.

Authors:  Francesca Pistollato; Elan L Ohayon; Ann Lam; Gillian R Langley; Thomas J Novak; David Pamies; George Perry; Eugenia Trushina; Robin S B Williams; Alex E Roher; Thomas Hartung; Stevan Harnad; Neal Barnard; Martha Clare Morris; Mei-Chun Lai; Ryan Merkley; P Charukeshi Chandrasekera
Journal:  Oncotarget       Date:  2016-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.